Hugo Biotech
PrivateLast Round
Grant
Dec 1, 2024
Total Funding Raised
$127.2M
Company Overview
Hugo Biotech operates in Healthcare & Life Sciences and is based in Beijing. Its latest recorded funding round was a Grant round in December 2024.
Hugo Biotech is a biotechnology company that specializes in high-throughput microbial sequencing technology and microbial genome big data analysis for the rapid identification of pathogenic microorganisms in clinical samples.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Biotech Equipment, Precision Medicine, Medical AI
Business Model
B2B
Customer Profile
Services & Consulting, Hardware Sales, Subscription SaaS
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Hugo Biotech Comparables
Compare Hugo Biotech with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| WillingMed Technology (Beijing) Co., Ltd. | 91% | |
| 金匙医学 | 91% | |
| Vision Medicals | 90% |
For institutional investors. Book with your work email.
Hugo Biotech Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Dec 1, 2024 | ||||
| Grant | Nov 1, 2024 | ||||
| Series C | Jan 21, 2022 | ||||
| Series B | Jul 20, 2021 | ||||
| Series A | Sep 28, 2020 | ||||
Series A Extension | Jun 29, 2020 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Hugo Biotech Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| CD Capital Asset Management | Series A |
| Lapam Capital | Series A |
| Northern Light Venture Capital | Series A, Seed |
| LYFE Capital | Series C, Series B |
| Gates Foundation | Grant |
| The Bill & Melinda Gates Foundation Trust | Grant |
| Sinovation Ventures | Series B, Series A |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 21, 2022
Raised $47.1M with LYFE Capital participating.
- Sep 28, 2020
$32M round led by Chuangxin Innovation Works, Lapam Capital, and Sinovation Ventures.
For institutional investors. Book with your work email.
Hugo Biotech Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Hugo Biotech's valuation, stock price, and market status.
Is Hugo Biotech a public or private company?
Hugo Biotech is a private company.
What is the current stock price of Hugo Biotech?
Hugo Biotech is a private company, so its shares have no public market price. Caplight tracks Hugo Biotech's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Hugo Biotech worth (valuation)?
Valuation information for Hugo Biotech is not publicly available.
Can I buy Hugo Biotech stock?
Hugo Biotech shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Hugo Biotech's last funding round?
Hugo Biotech's most recent funding round was Grant on December 1, 2024.
Who are the main investors in Hugo Biotech?
Key investors in Hugo Biotech include Lapam Capital, Northern Light Venture Capital, LYFE Capital, Gates Foundation, The Bill & Melinda Gates Foundation Trust.
Will Hugo Biotech IPO soon?
No public IPO plans have been announced for Hugo Biotech.
How can I track Hugo Biotech secondary market activity?
Caplight tracks bids, offers, and trades in Hugo Biotech's shares on secondary markets.